Literature DB >> 2350534

Lowering of theophylline clearance by isoniazid in slow and rapid acetylators.

B Santoso.   

Abstract

The effect of isoniazid (INH) pretreatment (400 mg daily for 2 weeks) on the elimination kinetics of theophylline (given intravenously as aminophylline equivalent to 151.2 mg theophylline) was investigated in 13 healthy male non-smokers. Amongst the 13 subjects studied, seven were rapid and six were slow acetylators. The mean clearance of theophylline was significantly lowered after INH (2.20 +/- 0.24 l h-1) (mean +/- s.e. mean) compared with the baseline value (2.80 +/- 0.24 l h-1). The volume of distribution at steady state was also lowered significantly after INH (0.42 +/- 0.01 l kg-1 vs 0.47 +/- 0.02 l kg-1). Consequently, there was no significant prolongation of theophylline half-life after INH (7.0 +/- 0.3 h vs 6.7 +/- 0.4 h control). The lowering of theophylline clearance by INH may be related to acetylator status since slow acetylators showed a greater interaction than rapid acetylators. However, this difference was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350534      PMCID: PMC1380157          DOI: 10.1111/j.1365-2125.1990.tb03681.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Interaction between isoniazid and theophylline.

Authors:  P Höglund; L G Nilsson; O Paulsen
Journal:  Eur J Respir Dis       Date:  1987-02

2.  Diphenylhydantoin intoxication. A complication of isoniazid therapy.

Authors:  H Kutt; R Brennan; H Dehejia; K Verebely
Journal:  Am Rev Respir Dis       Date:  1970-03

3.  Interaction of isoniazid and warfarin.

Authors:  A R Rosenthal; T H Self; E D Baker; R A Linden
Journal:  JAMA       Date:  1977-11-14       Impact factor: 56.272

4.  Carbamazepine intoxication caused by interaction with isoniazid.

Authors:  V C Valsalan; G L Cooper
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

5.  Reversal of the effects of isoniazid on hepatic cytochrome P-450 by potassium ferricyanide.

Authors:  S F Muakkassah; W R Bidlack; W C Yang
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

Review 6.  Isoniazid interactions.

Authors:  A M Baciewicz; T H Self
Journal:  South Med J       Date:  1985-06       Impact factor: 0.954

7.  Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity.

Authors:  M J Brodie; A R Boobis; C J Hillyard; G Abeyasekera; I MacIntyre; B K Park
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

8.  Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.

Authors:  K V Rao; D A Mitchison; N G Nair; K Prema; S P Tripathy
Journal:  Br Med J       Date:  1970-08-29

9.  Effects of isoniazid treatment on selected hepatic mixed-function oxidases.

Authors:  S A Rice; R E Talcott
Journal:  Drug Metab Dispos       Date:  1979 Sep-Oct       Impact factor: 3.922

10.  Diazepam interaction with antituberculosis drugs.

Authors:  H R Ochs; D J Greenblatt; G M Roberts; H J Dengler
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

View more
  7 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Theophylline and isoniazid.

Authors:  J R Thompson; T H Self
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 3.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 4.  Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Authors:  Nina Isoherranen; Justin D Lutz; Sophie P Chung; Houda Hachad; Rene H Levy; Isabelle Ragueneau-Majlessi
Journal:  Chem Res Toxicol       Date:  2012-09-27       Impact factor: 3.739

5.  PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.

Authors:  Ankit Balhara; Saranjit Singh
Journal:  Pharm Res       Date:  2021-09-13       Impact factor: 4.200

6.  Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.

Authors:  Khaled Abduljalil; Iain Gardner; Masoud Jamei
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

Review 7.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.